|21.33||+0.09 / +0.42%|
Data as of 1:00pm ET
|21.33||+0.0026 / +0.01%|
The 6 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 24.00, with a high estimate of 29.00 and a low estimate of 20.00. The median estimate represents a +12.52% increase from the last price of 21.33.
The current consensus among 7 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.